Description

Semaglutide

Semaglutide is an innovative medication primarily used to control blood sugar levels in adults with type 2 diabetes. It functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that mimics the natural hormone incretin to stimulate insulin release.

What Is Semaglutide Prescribed For?

There are different brands of semaglutide, such as Wegovy®, Ozempic® and Rybelsus®, which are FDA-approved for various conditions. While its main indication is for the treatment of type 2 diabetes, semaglutide has been identified as a potential aid for weight loss in qualifying individuals. It works by reducing hunger, slowing gastric emptying and promoting a feeling of fullness after meals, which can lead to a decrease in overall caloric intake.

Clinical trials have highlighted its effectiveness in weight management when combined with diet and exercise. However, it should be used under the guidance of a healthcare professional, and the benefits and risks should be carefully evaluated on an individual basis. Additionally, a holistic approach to weight management, including diet and exercise, should be considered alongside medication when seeking sustainable weight loss.

Semaglutide is administered once a week by injection, which makes it more convenient than other diabetes medications that need to be taken several times a day.

Dosage, Concentration and Route of Administration

Dosage: Seek advice from a licensed physician, medical director or other healthcare provider

Concentration (per mL): 5mg/mL, 3mL fill

Route of Administration: For SQ injection only

Precautions/Side Effects

As with any medication, semaglutide may cause side effects. Common reactions include gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain and constipation. Some individuals may experience more severe side effects, such as pancreatic inflammation, changes in vision or low blood sugar when used with other diabetes medications. It is not suitable for use in people with type 1 diabetes or diabetic ketoacidosis. Additionally, it is not approved for anyone under 18 years old.  It is crucial to discuss all potential risks with a healthcare provider before starting treatment with semaglutide.

Storage

Store at controlled room temperature.